The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.
Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian BA, Bonuccelli A, Peroni D, Michelucci R, Striano P.
Seizure. 2019 Oct;71:247-257. doi: 10.1016/j.seizure.2019.08.012. Epub 2019 Aug 23.
International consensus on diagnosis and management of Dravet syndrome.
Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J.
Epilepsia. 2022 Jul;63(7):1761-1777. doi: 10.1111/epi.17274. Epub 2022 May 12.
Myoclonic-astatic epilepsy.
Doose H.
Epilepsy Res Suppl. 1992;6:163-8.
Juvenile myoclonic epilepsy.
Timmings PL, Richens A.
BMJ. 1992 Jul 4;305(6844):4-5. doi: 10.1136/bmj.305.6844.4.
Juvenile myoclonic epilepsy.
Clement MJ, Wallace SJ.
Arch Dis Child. 1988 Sep;63(9):1049-53. doi: 10.1136/adc.63.9.1049.
Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
Poke G, Stanley J, Scheffer IE, Sadleir LG.
Neurology. 2023 Mar 28;100(13):e1363-e1375. doi: 10.1212/WNL.0000000000206758. Epub 2022 Dec 29.
Progressive myoclonic epilepsy.
Zupanc ML, Legros B.
Cerebellum. 2004;3(3):156-71. doi: 10.1080/14734220410035356.
Epilepsy with myoclonic absences.
Bureau M, Tassinari CA.
Brain Dev. 2005 Apr;27(3):178-84. doi: 10.1016/j.braindev.2004.01.008.
Benign myoclonic epilepsy in infancy.
Dravet C, Bureau M.
Adv Neurol. 2005;95:127-37.
Epilepsy with myoclonic absences.
Genton P, Bureau M.
CNS Drugs. 2006;20(11):911-6. doi: 10.2165/00023210-200620110-00004.
